Announcements
- Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
- Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
- Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
- Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
- Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
- Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
- Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference
- Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
- Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024
- Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference
More ▼
Key statistics
On Tuesday, Adaptive Biotechnologies Corp (1HM:DEU) closed at 3.04, 43.68% above the 52 week low of 2.11 set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.76 |
---|---|
High | 3.20 |
Low | 2.76 |
Bid | 3.07 |
Offer | 3.15 |
Previous close | 3.13 |
Average volume | 186.20 |
---|---|
Shares outstanding | 147.37m |
Free float | 144.28m |
P/E (TTM) | -- |
Market cap | 508.42m USD |
EPS (TTM) | -1.48 USD |
Data delayed at least 15 minutes, as of Jun 04 2024.
More ▼